Amgen (AMGN)

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Top Biotech Stocks to Buy on Trump Victory

By Nov 11, 2016

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House.

27 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 7, 2016

This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Corporate Tax Rates: 10 U.S. Companies Paying the Highest Taxes, 10 U.S. Companies Paying the Lowest Taxes

By William White, InvestorPlace Writer Nov 3, 2016

WalletHub has released its list of the companies in the United States with the highest, and the lowest, corporate tax rates.

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

By Dana Blankenhorn, InvestorPlace Contributor Nov 1, 2016

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there.

Why McKesson Corporation (MCK), Amgen, Inc. (AMGN) and Electronic Arts Inc. (EA) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Oct 28, 2016

Electronic Arts (EA), Amgen (AMGN) and McKesson (MCK) never even had a chance of ending Friday with a gain.

Hottest Manufacturing Stocks Now – DAIO AMCC CYTK SMCI

By Portfolio Grader Oct 28, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Amgen, Inc. (AMGN) Stock Sinks Despite Q3 Earnings Beat

By William White, InvestorPlace Writer Oct 28, 2016

Amgen, Inc. (AMGN) stock was taking hits on Friday after the company released its earnings report for the third quarter of 2016.

21 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 17, 2016

This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

How to Play a Down and Out Amgen, Inc. (AMGN) Stock

By Tyler Craig, Tales of a Technician Oct 12, 2016

Biotech stocks suffered during Monday's downdraft. With leaders like Amgen (AMGN) now trending lower, the time for bear plays is at hand.

24 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 10, 2016

24 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

25 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 3, 2016

25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

3 Reasons Not to Lose Faith in Amgen, Inc. (AMGN)

By James Brumley, InvestorPlace Feature Writer Sep 28, 2016

Amgen (AMGN) may have missed the mark with one trial, but that's not unusual or alarming within the world of biopharma.

10 Biotechnology Stocks to Buy Now

By Portfolio Grader Sep 26, 2016

The grades of 10 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

Depomed Inc (DEPO) Stock Soars on Sale Buzz

By William White, InvestorPlace Writer Sep 16, 2016

Depomed (DEPO) stock was up on Friday following reports that the company is considering a sale after fighting off a takeover last year.

Why Pandora Media Inc (P), Raptor Pharmaceutical Corp. (RPTP) and SolarCity Corp (SCTY) Are 3 of Today’s Best Stocks

By Todd Shriber, InvestorPlace Contributor Sep 12, 2016

Pandora (P), Raptor Pharmaceuticals (RPTP) and SolarCity (SCTY) were among the leaders on a day in which the Fed lifted the broader markets to a resounding rebound.